<bill session="117" type="h" number="349" updated="2023-01-11T13:43:34Z">
  <state datetime="2021-01-19">REFERRED</state>
  <status>
    <introduced datetime="2021-01-19"/>
  </status>
  <introduced datetime="2021-01-19"/>
  <titles>
    <title type="display">Coronavirus Vaccine and Therapeutic Development Act of 2021</title>
    <title type="official" as="introduced">To direct the Secretary of Health and Human Services to award contracts, grants, and cooperative agreements to expand and enhance capacity for manufacturing covered products to prevent and control the spread of SARS-CoV-2 and COVID-19.</title>
    <title type="short" as="introduced">Coronavirus Vaccine and Therapeutic Development Act of 2021</title>
  </titles>
  <sponsor bioguide_id="K000382"/>
  <cosponsors>
    <cosponsor bioguide_id="B001303" joined="2021-01-28"/>
    <cosponsor bioguide_id="B001285" joined="2021-01-28"/>
    <cosponsor bioguide_id="D000627" joined="2021-02-24"/>
    <cosponsor bioguide_id="F000462" joined="2021-02-02"/>
    <cosponsor bioguide_id="J000294" joined="2021-01-19"/>
    <cosponsor bioguide_id="K000381" joined="2021-02-24"/>
    <cosponsor bioguide_id="S001216" joined="2021-02-02"/>
    <cosponsor bioguide_id="S001185" joined="2021-02-02"/>
    <cosponsor bioguide_id="S001159" joined="2021-02-02"/>
    <cosponsor bioguide_id="T000482" joined="2021-01-28"/>
    <cosponsor bioguide_id="W000788" joined="2021-01-28"/>
  </cosponsors>
  <actions>
    <action datetime="2021-01-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-01-19" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2021-02-02">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-02-05">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR H393"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Congressional oversight"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Immunology and vaccination"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Manufacturing"/>
    <term name="Public contracts and procurement"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2021-05-17T18:11:45Z" status="Introduced in House">Coronavirus Vaccine and Therapeutic Development Act of 2021

This bill directs the Department of Health and Human Services (HHS) to increase the supply of vaccines and medical products that prevent or control COVID-19 (i.e., coronavirus disease 2019). To increase supplies, HHS must, as appropriate, award grants and enter other transactions to expand relevant research, procurement, and production activities.

HHS must report to Congress on these actions. The report must assess and detail plans to enhance the supply chain and manufacturing capacity for the vaccines and products. It must also include plans to support domestic and international vaccination programs.</summary>
</bill>
